Business Context and Reporting Period
This Form 6-K is filed by Prana Biotechnology Limited (not Alterity Therapeutics Ltd as indicated in metadata) for the month of June 2017, with the report signed on June 26, 2017. The registrant is a foreign private issuer headquartered in Carlton, Victoria, Australia. The filing serves to notify the SEC of a Change of Address (Exhibit 99.1).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is administrative in nature and contains no financial statements or performance data.
Material Changes
The only material change disclosed in this filing is the update to the registrant's principal executive office address. No financial or operational changes versus the prior period are reported.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the address change notification and incorporation by reference into existing registration statements (Form F-3 and Form S-8).
Investor Verification Checklist
- Verify the new principal executive office address for Prana Biotechnology Limited.
- Confirm the discrepancy between the metadata company name (Alterity Therapeutics Ltd) and the actual registrant (Prana Biotechnology Limited).
- Review the referenced Registration Statements (File No. 333-199783 and 333-153669) for financial data, as this 6-K contains none.